HOME >> BIOLOGY >> NEWS
Tracing a killer's path in Lou Gehrig's disease

Two papers in the July 8, 2004, issue of Neuron shed light on how a mutant form of a normally protective protein in the cells of sufferers of amyotrophic lateral sclerosis targets the "power plants" of motor neurons, killing the neurons and ultimately resulting in paralysis and death.

The culprit is a mutant form of the enzyme superoxide dismutase (SOD1), which normally protects cells from harmful reactive oxygen species. However, about 3% of people with ALS have a mutant form of the enzyme.

Don Cleveland and his colleagues conducted experiments in mice showing that the mutant SOD1 protein selectively migrates to the mitochondria of spinal cord neurons, where it links itself to the mitochondrial membrane.

Mitochondria are the cells' power plants, converting glucose into chemical energy that drives cellular processes. They are also the headquarters of the cells' "suicide" machinery, which triggers the death of cells that are malfunctioning or no longer needed--a process called apoptosis.

"This study offers one of the first glimpses into how cells from the spinal cord may be selectively targeted for degeneration in models of ALS," wrote the researchers.

"We propose that the universal association of SOD1 mutant exclusively within affected tissues represents the common property of these mutants that initiates a cascade of damage," they wrote.

In a second paper, Robert H. Brown, Jr., and his colleagues shed light on a specific mechanism by which the mutant SOD1 kills spinal cord neurons once it reaches their mitochondria.

Brown and his colleagues discovered that, in both mouse and human spinal cord neurons, mutant SOD1 specifically links itself to a key mitochondrial protein, called Bcl-2, that normally suppresses the apoptotic machinery of cells. Bcl-2 is also important in maintaining the function of the mitochondrial membrane. The researchers did not find evidence of such linkage in liver cell mitochondria,
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
7-Jul-2004


Page: 1 2

Related biology news :

1. Tracing genes, biologists show lizard migration is traced to Florida
2. Tracing the neural circuitry of second sight
3. Tracing the evolution of sex chromosomes
4. Elusive cancer killers deep-sea hideout discovered after a nearly 20-year hunt
5. First of crop killers genome sequence available
6. New findings are a window into the late stages of Lou Gehrigs disease
7. Abnormally high number of Lou Gehrigs disease cases identified among Gulf War veterans
8. Gene therapy delays death in mouse with symptoms of Lou Gehrigs disease
9. Salk news: gene therapy for Lou Gehrigs disease
10. Gene discovery may shed light on carpel tunnel syndrome and Lou Gehrigs disease
11. Gene therapy holds promise for treating inherited Lou Gehrigs Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... In its June 22 online post, ... Dr. James L. Sherley, M.D., Ph.D., founder and director of stem cell biotechnology company ... on June 16 that starting July 5 it would begin offering free ...
(Date:6/11/2020)... ... 08, 2020 , ... Cryo-Cell International’s announcement comes on the ... in the medical field. The face masks will be distributed nationwide to obstetrical ... day to provide healthcare to pregnant women. The delivery of masks is scheduled ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... software developer and solutions provider, today reported that the implementation of browser-based, ... compliance by 100%, resulting in greater efficiency for global biotechnology company, bioMérieux. ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... 2020 , ... The Indoor Lab, a leading provider of sensor solutions for ... types to ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using ... will provide a health performance index system that scores all aspects of compliance similar ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. , ... today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. ... studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level ...
(Date:6/23/2020)... , ... June 22, 2020 , ... ... offering an Amniosomes special offer. This includes buy three, get the fourth unit ... (888) 568-6909. , Amniotic derived exosomes, known as exosomes, have been a game ...
Breaking Biology Technology:
Cached News: